LUDIOMIL Side Effects

6386906-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Decreased Activity, Fatigue, Gamma-glutamyltransferase Increased, Liver Disorder, Malaise, Mental Impairment, Unevaluable Event
on Oct 01, 2009 Female patient from JAPAN , 28 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased activity, fatigue, gamma-glutamyltransferase increased, liver disorder, malaise, mental impairment, unevaluable event. Ludiomil dosage: 10 Mg, Qd, Oral. During the same period patient was treated with PURSENNID (NCH) (SENNA GLYCOSIDES (CA SALTS OF PURIFIED SENNA EXTRACT) (3 Df, Qhs, Oral) (View Pursennid (nch) (senna Glycosides (ca Salts Of Purified Senna Extract) Review and Pursennid (nch) (senna Glycosides (ca Salts Of Purified Senna Extract) Label ), DEPAKENE (100 Mg, Bid, Oral) (View Depakene Review and Depakene Label ), SILECE (FLUNITRAZEPAM) (2 Df, Qhs, Oral) (View Silece (flunitrazepam) Review and Silece (flunitrazepam) Label ), BROTIZOLAM (BROTIZOLAM) (2 Df, Qhs, Oral) (View Brotizolam (brotizolam) Review and Brotizolam (brotizolam) Label ). Patient was hospitalized.

6382622-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Decreased Activity, Fatigue, Gamma-glutamyltransferase Increased, Liver Disorder, Malaise, Mental Impairment
Patient was taking Ludiomil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased activity, fatigue, gamma-glutamyltransferase increased, liver disorder, malaise, mental impairment on Sep 28, 2009 from JAPAN Additional patient health information: Female patient , 28 years of age, was diagnosed with depression (What is depression?) and. Ludiomil dosage: 10 Mg, Qd, Oral. During the same period patient was treated with DEPAKENE (100 Mg, Bid, Oral) (View Depakene Review and Depakene Label ), PURSENNID (NCH) (SENNA GLYCOSIDES (CA SALTS OF PURIFIED SENNA EXTRACT) (3 Df, Qhs, Oral) (View Pursennid (nch) (senna Glycosides (ca Salts Of Purified Senna Extract) Review and Pursennid (nch) (senna Glycosides (ca Salts Of Purified Senna Extract) Label ), SILECE (FLUNITRAZEPAM) (2 Df, Qhs, Oral) (View Silece (flunitrazepam) Review and Silece (flunitrazepam) Label ), BROTIZOLAM (BROTIZOLAM) (2 Df, Qhs, Oral) (View Brotizolam (brotizolam) Review and Brotizolam (brotizolam) Label ). Patient was hospitalized.

6381658-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Decreased Activity, Fatigue, Gamma-glutamyltransferase Increased, Liver Disorder, Malaise, Mental Impairment
Adverse event was reported on Oct 01, 2008 by a Female patient taking Ludiomil (View Usage) (Dosage: 10 Mg, Qd) was diagnosed with depression (What is depression?) and. Location: JAPAN , 28 years of age, After Ludiomil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased activity, fatigue, gamma-glutamyltransferase increased, liver disorder, malaise, mental impairment. During the same period patient was treated with PURSENNID (NCH) (3 Df, Qhs) (View Pursennid (nch) Review and Pursennid (nch) Label ), DEPAKENE (100 Mg, Bid) (View Depakene Review and Depakene Label ), SILECE (2 Df, Qhs) (View Silece Review and Silece Label ), BROTIZOLAM (2 Df, Qhs) (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.

6377669-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Decreased Activity, Fatigue, Gamma-glutamyltransferase Increased, Liver Disorder, Malaise, Mental Impairment
on Sep 09, 2009 Female patient from JAPAN , 28 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased activity, fatigue, gamma-glutamyltransferase increased, liver disorder, malaise, mental impairment. Ludiomil dosage: 10 Mg, Qd. During the same period patient was treated with DEPAKENE (100 Mg, Bid) (View Depakene Review and Depakene Label ), PURSENNID (NCH) (3 Df, Qhs) (View Pursennid (nch) Review and Pursennid (nch) Label ), SILECE (2 Df, Qhs) (View Silece Review and Silece Label ), BROTIZOLAM (2 Df, Qhs) (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.


6377669-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Decreased Activity, Fatigue, Gamma-glutamyltransferase Increased, Liver Disorder, Malaise, Mental Impairment
on Sep 09, 2009 Female patient from JAPAN , 28 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased activity, fatigue, gamma-glutamyltransferase increased, liver disorder, malaise, mental impairment. Ludiomil dosage: 10 Mg, Qd. During the same period patient was treated with DEPAKENE (100 Mg, Bid) (View Depakene Review and Depakene Label ), GLYSENNID (3 Df, Qhs) (View Glysennid Review and Glysennid Label ), SILECE (2 Df, Qhs) (View Silece Review and Silece Label ), BROTIZOLAM (2 Df, Qhs) (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.

6203312-4 | Cardio-respiratory Arrest, Completed Suicide, Encephalopathy, Loss Of Consciousness
Patient was taking Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: cardio-respiratory arrest, completed suicide, encephalopathy, loss of consciousness on May 25, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, was diagnosed with depression (What is depression?) and. Ludiomil dosage: Unk. Patient was hospitalized.

6171954-0 | Abnormal Dreams, Agitation, Anxiety, Crying, Depression, Headache, Hunger, Nausea, Pollakiuria
Adverse event was reported on Apr 17, 2009 by a Male patient taking Ludiomil (View Usage) (Dosage: 75 Mg, Bid) was diagnosed with depression (What is depression?), anxiety (What is anxiety?), nervousness and. Location: BRAZIL , weighting 233.7 lb, Patient experienced the following unwanted or unexpected effects: abnormal dreams, agitation, anxiety (What is anxiety?), crying, depression (What is depression?), headache (What is headache?), hunger, nausea (What is nausea?), pollakiuria. During the same period patient was treated with TRILEPTAL (300 Mg, Tid) (View Trileptal Review and Trileptal Label ), OLCADIL (16 Mg/d) (View Olcadil Review and Olcadil Label ), TEGRETOL (10 Ml, Bid) (View Tegretol Review and Tegretol Label ).

6050502-X | Depressed Level Of Consciousness, Fatigue, Intentional Overdose
on Jan 16, 2009 Female patient from JAPAN , child 11 years of age, was treated with Ludiomil (View Usage). Patient had the following side effects: depressed level of consciousness, fatigue, intentional overdose. Ludiomil dosage: 650 Mg. During the same period patient was treated with SEPAZON (28 Mg) (View Sepazon Review and Sepazon Label ). Patient was hospitalized and became disabled.

6042646-3 | Depressed Level Of Consciousness, Fatigue, Intentional Overdose
on Jan 07, 2009 Female patient from JAPAN , child 11 years of age, was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: depressed level of consciousness, fatigue, intentional overdose. Ludiomil dosage: 650 Mg. During the same period patient was treated with SEPAZON (28 Mg) (View Sepazon Review and Sepazon Label ). Patient was hospitalized and became disabled.

6026968-8 | Amnesia
Patient was taking Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia on Dec 25, 2008 from BRAZIL Additional patient health information: Male patient , 59 years of age, weighting 154.3 lb, was diagnosed with depression (What is depression?) and. Ludiomil dosage: 25mg, 2 Tablets/day. During the same period patient was treated with BROMAZEPAM (6mg, 2 Tablets) (View Bromazepam Review and Bromazepam Label ).

6019605-X | Altered State Of Consciousness, Blood Glucose Increased, Cardio-respiratory Arrest, Cardioversion, Dysphagia, Dysphonia, Endotracheal Intubation, Hypotension, Liver Function Test Abnormal
Adverse event was reported on Dec 22, 2008 by a Female patient taking Ludiomil (View Usage) (Dosage: 10 Mg, Tid) was diagnosed with depression (What is depression?) and. Location: JAPAN , weighting 130.1 lb, Patient had the following side effects: altered state of consciousness, blood glucose increased, cardio-respiratory arrest, cardioversion, dysphagia, dysphonia, endotracheal intubation, hypotension, liver function test abnormal. Patient was hospitalized.

5962072-2 | Abdominal Pain Upper, Blood Thyroid Stimulating Hormone Decreased, Depression, Dry Mouth, Eating Disorder, Hyperthyroidism, Neck Pain, Oesophagitis, Pharyngitis
on Nov 12, 2008 Female patient from BRAZIL , 40 years of age, weighting 130.1 lb, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: abdominal pain upper, blood thyroid stimulating hormone decreased, depression (What is depression?), dry mouth, eating disorder (What is eating disorder?), hyperthyroidism, neck pain, oesophagitis, pharyngitis. Ludiomil dosage: 25 Mg, Qd.

5953218-0 | Convulsion, Depression
on Nov 05, 2008 Female patient from JAPAN , 58 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, depression (What is depression?). Ludiomil dosage: 60 Mg, Qd. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), DOGMATYL (150 Mg) (View Dogmatyl Review and Dogmatyl Label ). Patient was hospitalized.

5947416-X | Convulsion
Patient was taking Ludiomil (View Usage). Patient had the following side effects: convulsion on Oct 24, 2008 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with depression (What is depression?) and. Ludiomil dosage: 60 Mg. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

5919298-3 | Apathy, Asthenia, Depersonalisation, Depressed Level Of Consciousness, Pyrexia, Somnolence, Toxic Encephalopathy
Adverse event was reported on Oct 06, 2008 by a Female patient taking Ludiomil (View Usage) (Dosage: ) . Location: SPAIN , 65 years of age, After Ludiomil was administered, patient had the following side effects: apathy, asthenia, depersonalisation, depressed level of consciousness, pyrexia, somnolence, toxic encephalopathy. During the same period patient was treated with LEXATIN (1.5 Mg/day) (View Lexatin Review and Lexatin Label ), ORFIDAL (View Orfidal Review and Orfidal Label ), SEROXAT (10 Mg) (View Seroxat Review and Seroxat Label ), CIPROFLOXACIN (4 Cycles Of 1 Week) (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

5911961-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Fatigue, Gamma-glutamyltransferase Increased, Liver Disorder, Malaise, Mental Impairment
on Oct 01, 2008 Female patient from JAPAN , 28 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, fatigue, gamma-glutamyltransferase increased, liver disorder, malaise, mental impairment. Ludiomil dosage: 10 Mg, Qd. During the same period patient was treated with DEPAKENE (100 Mg, Bid) (View Depakene Review and Depakene Label ), PURSENNID /SCH/ (3 Df, Qhs) (View Pursennid /sch/ Review and Pursennid /sch/ Label ), SILECE (2 Df, Qhs) (View Silece Review and Silece Label ), GOODMIN (2 Df, Qhs) (View Goodmin Review and Goodmin Label ). Patient was hospitalized.

5902906-0 | Liver Disorder
on Sep 22, 2008 Female patient from JAPAN , 28 years of age, was treated with Ludiomil (View Usage). Patient had the following side effects: liver disorder. Ludiomil dosage: Unk.

5877042-2 | Conversion Disorder, Hallucination, Visual
Patient was taking Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: conversion disorder, hallucination, visual on Sep 02, 2008 from JAPAN Additional patient health information: Female patient , 64 years of age, was diagnosed with depression (What is depression?) and. Ludiomil dosage: 25 Mg/day. Patient was hospitalized.

5811119-2 | Erythema Multiforme
Adverse event was reported on Jul 07, 2008 by a Female patient taking Ludiomil (View Usage) (Dosage: 25 Mg /day) . Location: JAPAN , 19 years of age, Patient experienced the following unwanted or unexpected effects: erythema multiforme. During the same period patient was treated with SOLANAX (Unk) (View Solanax Review and Solanax Label ).

5764774-X | Conversion Disorder, Hallucination
on Jun 06, 2008 Female patient from JAPAN , 64 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient had the following side effects: conversion disorder, hallucination. Ludiomil dosage: 25 Mg/day. During the same period patient was treated with MUCOSTA (300 Mg/day) (View Mucosta Review and Mucosta Label ), THYRADIN (1 Mg Daily) (View Thyradin Review and Thyradin Label ), DESYREL (150 Mg/day) (View Desyrel Review and Desyrel Label ).

5764768-4 | Anorexia, Depressive Symptom
on Jun 02, 2008 Female patient from , 62 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: anorexia, depressive symptom. Ludiomil dosage: 75 Mg, Every Other Day. During the same period patient was treated with ALPRAZ (0.5 Mg, 1 Tab/night) (View Alpraz Review and Alpraz Label ), CARBOLITIUM (300 Mg, 1 Tab Morning + 1 In The Night) (View Carbolitium Review and Carbolitium Label ).

5756041-5 | Anxiety, Asthenia, Decreased Appetite, Depressed Mood, Eating Disorder, Feeling Abnormal, Gastrointestinal Tube Insertion, Irritability
Patient was taking Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), asthenia, decreased appetite, depressed mood, eating disorder (What is eating disorder?), feeling abnormal, gastrointestinal tube insertion, irritability on May 23, 2008 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?), dysaesthesia, anorexia and. Ludiomil dosage: 75 Mg/day. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), QUETIAPINE FUMARATE (150 Mg) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), OLANZAPINE (5 Mg) (View Olanzapine Review and Olanzapine Label ), FLUVOXAMINE MALEATE (100 Mg/day) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), SULPIRIDE (150 Mg) (View Sulpiride Review and Sulpiride Label ). Patient was hospitalized.

5703686-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asphyxia, Aspiration, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Blood Potassium Decreased, Blood Sodium Increased
Adverse event was reported on Apr 10, 2008 by a Female patient taking Ludiomil (View Usage) (Dosage: 100 Df) was diagnosed with depression (What is depression?) and. Location: JAPAN , 37 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asphyxia, aspiration, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased, blood sodium increased. During the same period patient was treated with PAXIL (100 Df,) (View Paxil Review and Paxil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5693776-7 | Cardio-respiratory Arrest, Overdose
on Mar 31, 2008 Female patient from JAPAN , 37 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: cardio-respiratory arrest, overdose. Ludiomil dosage: 100 Df. During the same period patient was treated with PAXIL (100 Df,) (View Paxil Review and Paxil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5680245-3 | Cardio-respiratory Arrest, Overdose
on Mar 25, 2008 Female patient from JAPAN , 37 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, overdose. Ludiomil dosage: 100 Df. During the same period patient was treated with PAXIL (100 Df,) (View Paxil Review and Paxil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5659594-0 | Cardio-respiratory Arrest, Overdose
Patient was taking Ludiomil (View Usage). Patient had the following side effects: cardio-respiratory arrest, overdose on Mar 07, 2008 from JAPAN Additional patient health information: Female patient , 37 years of age, was diagnosed with depression (What is depression?) and. Ludiomil dosage: 100 Df. During the same period patient was treated with PAXIL (100 Df,) (View Paxil Review and Paxil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5659459-4 | Amnesia, Visual Field Defect
Adverse event was reported on Mar 03, 2008 by a Male patient taking Ludiomil (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: JAPAN , 28 years of age, After Ludiomil was administered, patient had the following side effects: amnesia, visual field defect. During the same period patient was treated with TOLEDOMIN (View Toledomin Review and Toledomin Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), PEMOLINE (View Pemoline Review and Pemoline Label ), MYSLEE (View Myslee Review and Myslee Label ), WYPAX (View Wypax Review and Wypax Label ), LEXOTAN (View Lexotan Review and Lexotan Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ).

5657917-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Abnormal
on Feb 29, 2008 Male patient from JAPAN , 58 years of age, weighting 183.0 lb, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase abnormal. Ludiomil dosage: 10 Mg, Tid. During the same period patient was treated with GASTER D (20 Mg, Qd) (View Gaster D Review and Gaster D Label ), SERENACE (2.25 Mg, Tid) (View Serenace Review and Serenace Label ), AKINETON (3 Mg, Tid) (View Akineton Review and Akineton Label ).

5631791-X | Delirium, Renal Disorder
on Feb 14, 2008 Male patient from JAPAN , 90 years of age, was treated with Ludiomil (View Usage). Patient had the following side effects: delirium, renal disorder. Ludiomil dosage: . During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ).

5608284-9 | Liver Disorder, Toxic Epidermal Necrolysis
Patient was taking Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: liver disorder, toxic epidermal necrolysis on Jan 25, 2008 from JAPAN Additional patient health information: Female patient , 57 years of age, . Ludiomil dosage: 10mg/day. During the same period patient was treated with ALEVIATIN (View Aleviatin Review and Aleviatin Label ).

5598094-3 | Liver Disorder, Toxic Epidermal Necrolysis
Adverse event was reported on Jan 15, 2008 by a Female patient taking Ludiomil (View Usage) (Dosage: 10mg/day) . Location: JAPAN , 57 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder, toxic epidermal necrolysis.

5576015-7 | Chest Discomfort, Monoplegia, Somnolence, Tongue Paralysis
on Dec 19, 2007 Female patient from JAPAN , 55 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient had the following side effects: chest discomfort, monoplegia, somnolence, tongue paralysis. Ludiomil dosage: 25 Mg, Tid.

5556917-8 | Asthenia, Dizziness, Labyrinthitis, Muscular Weakness
on Dec 07, 2007 Female patient from BRAZIL , 83 years of age, weighting 152.1 lb, was diagnosed with depression (What is depression?), angina pectoris, coronary artery disease (What is coronary artery disease?) and was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: asthenia, dizziness (What is dizziness?), labyrinthitis, muscular weakness. Ludiomil dosage: 75 Mg, Qhs. During the same period patient was treated with LEXOTAN (1.5 Mg, Bid) (View Lexotan Review and Lexotan Label ), SUSTRATE (Unk, Prn) (View Sustrate Review and Sustrate Label ), DILACORON (240 Mg/d) (View Dilacoron Review and Dilacoron Label ).

5541565-6 | Insomnia, Malaise, Vomiting
Patient was taking Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: insomnia, malaise, vomiting on Dec 04, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 31 years of age, weighting 149.9 lb, was diagnosed with attention deficit/hyperactivity disorder and. Ludiomil dosage: 25 Mg/day. During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ).

5432543-6 | Accidental Exposure, Gastric Lavage
Adverse event was reported on Aug 22, 2007 by a Male patient taking Ludiomil (View Usage) (Dosage: 10 Mg, Once/single) . Location: JAPAN , child 1 years of age, Patient had the following side effects: accidental exposure, gastric lavage. Patient was hospitalized.

5378109-8 | Dysuria, Nephrolithiasis, Pollakiuria, Renal Cyst, Renal Pain, Urinary Retention, Urinary Tract Infection
on Jun 22, 2007 Female patient from SWITZERLAND , 28 years of age, was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: dysuria, nephrolithiasis, pollakiuria, renal cyst, renal pain, urinary retention, urinary tract infection (What is urinary tract infection?). Ludiomil dosage: 1 Dosage From/day. Patient was hospitalized.

5373214-4 | Femur Fracture, Surgery
on Jun 19, 2007 Female patient from JAPAN , 81 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: femur fracture, surgery (What is surgery?). Ludiomil dosage: 10 Mg, Qhs.

5363180-X | Hyponatraemia
Patient was taking Ludiomil (View Usage). Patient had the following side effects: hyponatraemia on Jun 13, 2007 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with depression (What is depression?) and. Ludiomil dosage: Unk, Unk.

5360136-8 | Femur Fracture, Gait Disturbance, Surgery
Adverse event was reported on Jun 08, 2007 by a Female patient taking Ludiomil (View Usage) (Dosage: 10 Mg, Qhs) was diagnosed with depression (What is depression?) and. Location: JAPAN , 81 years of age, After Ludiomil was administered, patient had the following side effects: femur fracture, gait disturbance, surgery (What is surgery?).

5358417-7 | Anxiety, Delirium, Hyperhidrosis, Hyperreflexia, Nausea, Serotonin Syndrome, Tremor, Unresponsive To Stimuli
on Jun 06, 2007 Male patient from AUSTRIA , 76 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), delirium, hyperhidrosis, hyperreflexia, nausea (What is nausea?), serotonin syndrome, tremor, unresponsive to stimuli. Ludiomil dosage: . During the same period patient was treated with SEROXAT ^NOVO NORDISK^ (View Seroxat ^novo Nordisk^ Review and Seroxat ^novo Nordisk^ Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), QUILONORM (View Quilonorm Review and Quilonorm Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

5339755-0 | Hyponatraemia
on May 22, 2007 Female patient from JAPAN , 70 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient had the following side effects: hyponatraemia. Ludiomil dosage: .

5339729-X | Blood Creatine Phosphokinase Increased, Blood Urine Present, Congenital Central Nervous System Anomaly, Decreased Activity, Exercise Lack Of, Feeding Disorder, Hypercreatininaemia, Hyporeflexia
Patient was taking Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia, hyporeflexia on May 23, 2007 from JAPAN Additional patient health information: Male patient , weighting 8.40 lb, . Ludiomil dosage: . During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5295778-1 | Gastroenteritis, Vomiting
Adverse event was reported on Apr 02, 2007 by a Female patient taking Ludiomil (View Usage) (Dosage: 10 Mg/d) was diagnosed with depression (What is depression?) and. Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: gastroenteritis (What is gastroenteritis?), vomiting. During the same period patient was treated with PAXIL (20 Mg/d) (View Paxil Review and Paxil Label ), WARFARIN SODIUM (1 Mg/d) (View Warfarin Sodium Review and Warfarin Sodium Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ).

5293553-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Depressed Level Of Consciousness, Hepatic Function Abnormal, Intentional Overdose, Muscle Disorder, Suicide Attempt
on Mar 28, 2007 Male patient from JAPAN , 50 years of age, weighting 143.3 lb, was diagnosed with depression (What is depression?), insomnia and was treated with Ludiomil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, depressed level of consciousness, hepatic function abnormal, intentional overdose, muscle disorder (What is muscle disorder?), suicide attempt. Ludiomil dosage: 25 Mg, Qd. During the same period patient was treated with LEXOTAN (5 Mg/day) (View Lexotan Review and Lexotan Label ), NITRAZEPAM (10 Mg/day) (View Nitrazepam Review and Nitrazepam Label ), ROHYPNOL (2 Mg/day) (View Rohypnol Review and Rohypnol Label ). Patient was hospitalized.

5293074-X | Blood Creatine Phosphokinase Increased, Blood Urine Present, Congenital Central Nervous System Anomaly, Decreased Activity, Exercise Lack Of, Feeding Disorder, Hypercreatininaemia, Hyporeflexia
on Apr 02, 2007 Male patient from JAPAN , weighting 8.40 lb, was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia, hyporeflexia. Ludiomil dosage: . During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5289325-8 | Blood Lactate Dehydrogenase Increased, Bronchoalveolar Lavage Abnormal, C-reactive Protein Increased, Cell Marker Increased, Chest X-ray Abnormal, Fatigue, Interstitial Lung Disease, Lung Infiltration, Oxygen Saturation Decreased
Patient was taking Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, bronchoalveolar lavage abnormal, c-reactive protein increased, cell marker increased, chest x-ray abnormal, fatigue, interstitial lung disease, lung infiltration, oxygen saturation decreased on Mar 28, 2007 from JAPAN Additional patient health information: Female patient , 77 years of age, weighting 112.4 lb, was diagnosed with depression (What is depression?), thirst and. Ludiomil dosage: 75 Mg/d. During the same period patient was treated with TSUMURA BYAKKOKANINJINTO (9 G/d) (View Tsumura Byakkokaninjinto Review and Tsumura Byakkokaninjinto Label ), AMOBAN (7.5 Mg/d) (View Amoban Review and Amoban Label ), TECIPUL (2 Mg/d) (View Tecipul Review and Tecipul Label ). Patient was hospitalized.

5286070-X | Rhabdomyolysis
Adverse event was reported on Mar 22, 2007 by a Male patient taking Ludiomil (View Usage) (Dosage: 10 Mg/d) was diagnosed with depression (What is depression?) and. Location: JAPAN , 70 years of age, Patient had the following side effects: rhabdomyolysis. During the same period patient was treated with LENDORMIN (View Lendormin Review and Lendormin Label ).

5275137-8 | Serotonin Syndrome
on Mar 13, 2007 Female patient from JAPAN , 85 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). After Ludiomil was administered, patient had the following side effects: serotonin syndrome. Ludiomil dosage: 10 Mg/d. During the same period patient was treated with PAXIL (20 Mg/d) (View Paxil Review and Paxil Label ), WARFARIN SODIUM (1 Mg/d) (View Warfarin Sodium Review and Warfarin Sodium Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ).

5274087-0 | Blood Lactate Dehydrogenase Increased, Bronchoalveolar Lavage Abnormal, C-reactive Protein Increased, Cell Marker Increased, Chest X-ray Abnormal, Lung Infiltration, Pneumonitis, White Blood Cell Count Increased
on Mar 12, 2007 Female patient from JAPAN , 77 years of age, was diagnosed with depression (What is depression?) and was treated with Ludiomil (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, bronchoalveolar lavage abnormal, c-reactive protein increased, cell marker increased, chest x-ray abnormal, lung infiltration, pneumonitis, white blood cell count increased. Ludiomil dosage: .

5270670-7 | Serotonin Syndrome
Patient was taking Ludiomil (View Usage). Patient had the following side effects: serotonin syndrome on Mar 13, 2007 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with depression (What is depression?) and. Ludiomil dosage: 10 Mg/d. During the same period patient was treated with PAXIL (20 Mg/d) (View Paxil Review and Paxil Label ), WARFARIN SODIUM (1 Mg/d) (View Warfarin Sodium Review and Warfarin Sodium Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ).